Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Oncogene (4)
Oncogenesis (2)
Signal Transduction and Targeted Therapy (1)
Nature Communications (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (6)
Amendments and Corrections (1)
Reviews (1)

Subject Check one or more subjects to show results from those subjects only.

Biochemistry
Cancer
Cell biology
Genetics
Oncology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–8 of 8 results

Advanced filters: Author: Shourong Wu Clear advanced filters

Publisher Correction: NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation

Zheng Wu
Wei Duan
Shourong Wu
Amendments and Corrections22 Sept 2025
Oncogene

Volume: 44, P: 4100
NeuroD1 drives a KAT2A-FDFT1 signaling axis to promote cholesterol biosynthesis and hepatocellular carcinoma progression via histone H3K27 acetylation

Zheng Wu
Wei Duan
Shourong Wu
Research01 Sept 2025
Oncogene

Volume: 44, P: 4017-4031
Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic BCL2L12

Altered expression of splicing factors can contribute to tumour progression. Here the authors show that splicing factor BUD31 enhances ovarian cancer progression by promoting exon inclusion in the anti-apoptotic BCL2 family member, BCL2L12.

Zixiang Wang
Shourong Wang
Zhaojian Liu
ResearchOpen Access21 Oct 2022
Nature Communications

Volume: 13, P: 1-18
NFATc1-mediated activation of the pentose phosphate pathway and cell cycle dysregulation collectively drive tumor progression

Suyang Zhang
Guangyao Xu
Can Huang
ResearchOpen Access07 Nov 2025
Oncogenesis

Volume: 14, P: 1-12
p52-ZER6/IGF1R axis maintains cancer stem cell population to promote cancer progression by enhancing pro-survival mitophagy

Wenfang Li
Can Huang
Shourong Wu
Research21 May 2024
Oncogene

Volume: 43, P: 2115-2131
The p52-ZER6/G6PD axis alters aerobic glycolysis and promotes tumor progression by activating the pentose phosphate pathway

Yu Tang
Wenfang Li
Vivi Kasim
ResearchOpen Access28 Mar 2023
Oncogenesis

Volume: 12, P: 1-12
NeuroD1 promotes tumor cell proliferation and tumorigenesis by directly activating the pentose phosphate pathway in colorectal carcinoma

Zhuolin Li
Yuxin He
Vivi Kasim
Research16 Oct 2021
Oncogene

Volume: 40, P: 6736-6747
The two sides of chromosomal instability: drivers and brakes in cancer

Rendy Hosea
Sharon Hillary
Vivi Kasim
ReviewsOpen Access29 Mar 2024
Signal Transduction and Targeted Therapy

Volume: 9, P: 1-30